Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy

The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.

Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial

Biomarkers for early stage of acute respiratory distress syndrome in septic patients: surfactant protein D and Clara cell protein – topic of research paper in Health sciences. Download scholarly article PDF and

Frontiers Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies

Platelet P2Y12 signalling pathway in the dysregulated immune response during sepsis - Amoafo - British Journal of Pharmacology - Wiley Online Library

Staphylococcus aureus Bacteremia in Adults

2023 ACCP Annual Meeting November 11 ‐ 14, 2023 - 2023 - JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY - Wiley Online Library

AFMR Southeastern Regional Meeting Supplement, 2023

Bloodstream infections in critically ill patients: an expert statement

Management of Staphylococcus aureus Infections

Metabolites, Free Full-Text

Phenotyping of Methicillin-Resistant Staphylococcus aureus Using a Ratiometric Sensor Array

Frontiers Management of Staphylococcus aureus Bloodstream Infections

Examining the clinical impact of rapid multiplex polymerase chain reaction‐based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration - Britt - 2023 - Pharmacotherapy: The Journal

Antibiotic shows efficacy against complicated Staph bacteremia